The Effect of Sample Glucose Content on PNGase F-Mediated N-Glycan Release Analyzed by Capillary Electrophoresis
暂无分享,去创建一个
[1] H. Jankovics,et al. Enhanced Recombinant Protein Production of Soluble, Highly Active and Immobilizable PNGase F , 2022, Molecular Biotechnology.
[2] A. Guttman,et al. Multilevel capillary gel electrophoresis characterization of new antibody modalities. , 2021, Analytica chimica acta.
[3] E. van Tricht,et al. Four‐step approach to efficiently develop capillary gel electrophoresis methods for viral vaccine protein analysis , 2020, Electrophoresis.
[4] R. Deshaies. Multispecific drugs herald a new era of biopharmaceutical innovation , 2020, Nature.
[5] Jianwei Zhu,et al. Antibody glycosylation: impact on antibody drug characteristics and quality control , 2020, Applied Microbiology and Biotechnology.
[6] G. Járvás,et al. Comparative analysis of the human serum N-glycome in lung cancer, COPD and their comorbidity using capillary electrophoresis. , 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[7] A. Racher,et al. Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production , 2019, Metabolic engineering.
[8] M. Kinoshita,et al. A fast and convenient solid phase preparation method for releasing N-glycans from glycoproteins using trypsin- and peptide-N-glycosidase F (PNGase F)-impregnated polyacrylamide gels fabricated in a pipette tip. , 2019, Journal of pharmaceutical and biomedical analysis.
[9] M. Szigeti,et al. Sample Preparation Scale-Up for Deep N-glycomic Analysis of Human Serum by Capillary Electrophoresis and CE-ESI-MS* , 2019, Molecular & Cellular Proteomics.
[10] Mercedes Bonfill,et al. Biotechnological Production of Pharmaceuticals and Biopharmaceuticals in Plant Cell and Organ Cultures. , 2018, Current medicinal chemistry.
[11] U. Walker,et al. Pharmacological treatment options for cryopyrin-associated periodic syndromes , 2017, Expert review of clinical pharmacology.
[12] G. Járvás,et al. Enzymatic removal of N‐glycans by PNGase F coated magnetic microparticles , 2016, Electrophoresis.
[13] D. Ecker,et al. The therapeutic monoclonal antibody market , 2015, mAbs.
[14] R. Brodsky,et al. Paroxysmal nocturnal hemoglobinuria. , 2014, Blood.
[15] Pauline M Rudd,et al. Glycans as cancer biomarkers. , 2012, Biochimica et biophysica acta.
[16] Jianwei Zhu,et al. Mammalian cell protein expression for biopharmaceutical production. , 2012, Biotechnology advances.
[17] P. Tak,et al. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis , 2010, Science Translational Medicine.
[18] B. Murtaza,et al. Paroxysmal nocturnal hemoglobinuria. , 2008, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[19] N. Khachanova,et al. [Highly active multiple sclerosis: options for monoclonal antibody therapy]. , 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
[20] J. Lorsch. Practical steady-state enzyme kinetics. , 2014, Methods in enzymology.